Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Appl Microbiol Biotechnol ; 58(6): 797-805, 2002 May.
Article in English | MEDLINE | ID: mdl-12021801

ABSTRACT

We have investigated the methylotrophic yeast Hansenula polymorpha as a host for the co-integration and expression of multiple heterologous genes using an rDNA integration approach. The ribosomal DNA (rDNA) of H. polymorpha was found to consist of a single rDNA cluster of about 50-60 repeats of an 8-kb unit located on chromosome II. A 2.4-kb segment of H. polymorpha rDNA encompassing parts of the 25S, the complete 5S and the non-transcribed spacer region between 25S and 18S rDNA was isolated and inserted into conventional integrative H. polymorpha plasmids harboring the Saccharomyces- cerevisiae-derived URA3 gene for selection. These rDNA plasmids integrated homologously into the rDNA repeats of a H. polymorpha (odc1) host as several independent clusters. Anticipating that this mode of multiple-cluster integration could be used for the simultaneous integration of several distinct rDNA plasmids, the host strain was co-transformed with a mixture of up to three different plasmids, all bearing the same URA3 selection marker. Transformations indeed resulted in mitotically stable strains harboring one, two, or all three plasmids integrated into the rDNA. The overall copy number of the plasmids integrated did not exceed the number of rDNA repeats present in the untransformed host strain, irrespective of the number of different plasmids involved. Strains harboring different plasmids co-expressed the introduced genes, resulting in functional proteins. Thus, this approach provides a new and attractive tool for the rapid generation of recombinant strains that simultaneously co-produce several proteins in desired stoichiometric ratios.


Subject(s)
DNA, Ribosomal/genetics , Pichia/genetics , Transfection , Base Sequence , Cloning, Molecular , Fungal Proteins/genetics , Genetic Complementation Test , Molecular Sequence Data , Open Reading Frames , Plasmids , Sequence Homology, Nucleic Acid
2.
Exp Parasitol ; 95(4): 231-9, 2000 Aug.
Article in English | MEDLINE | ID: mdl-11038306

ABSTRACT

Schistosoma mansoni is a blood-dwelling trematode which can persist for several years in the vessels of the human host. The schistosomal surface has been extensively characterized by lectin binding studies, revealing the carbohydrate composition of the worm's tegument. Using fluorescent and scanning electron microscopy we demonstrate that the surface carbohydrates of cercariae and adult worms are the binding ligands for mannanbinding lectin (MBL), a serum protein that is part of the innate immune system. An in vitro complement activation assay with C1q-deficient complement suggests that MBL, in association with the serine proteases MASP-1 and MASP-2, is capable of fixing complement components on the schistosomal tegument and activating the complement cascade via the "MBL pathway." MBL is constitutively expressed by hepatocytes and present in the blood at a stable level. Since it is also a weak acute-phase protein and therefore upregulated in an acute-phase response we investigated the serum MBL levels in patients infected with Schistosoma sp. and in healthy control persons. An enzyme-linked immunosorbent assay indicated no differences between the two groups. Although our results suggest an involvement of MBL activated complement in vitro, its role in vivo remains to be clarified.


Subject(s)
Carrier Proteins/metabolism , Membrane Glycoproteins/metabolism , Schistosoma mansoni/metabolism , Animals , Carrier Proteins/blood , Collectins , Complement Activation/physiology , Female , Humans , Immunoenzyme Techniques , Lectins/metabolism , Male , Mannans/metabolism , Mice , Microscopy, Confocal , Microscopy, Electron, Scanning , Microscopy, Fluorescence , Schistosoma mansoni/ultrastructure
3.
Am J Trop Med Hyg ; 61(5): 776-9, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10586911

ABSTRACT

The intercellular adhesion molecule-1 (ICAM-1) is thought to be a receptor that mediates binding of Plasmodium falciparum-infected erythrocytes. Especially in vital organs, the binding of parasitized cells to the endothelium via ICAM-1 may lead to severe disease and death. Recently, a mutation in the coding region of ICAM-1, termed ICAM-1Kilifi, was described, causing a change from Lys to Met in the loop that interacts with rhinoviruses, lymphocytes, and parasitized red blood cells. Surprisingly, this mutation was shown to increase susceptibility of Kenyan children to severe malaria in one study. When we compared the distribution of ICAM-1Kilifi in two groups of Gabonese children enrolled in a case-control, matched-pair study who presented with either mild or severe malaria, we found that 55% of the patients with mild malaria were carriers whereas only 39% of those with severe malaria were carriers. The difference in the distribution of ICAM-1Kilifi homozygous pairs between the groups, as well as the distribution of ICAM-1Kilifi carriers, was statistically highly significant (P = 0.027 and P = 0.012, by the McNemar test). In a group of healthy school children from the same region, a distribution of 52% ICAM-1Kilifi carriers to 48% wild-type individuals was found. In a survey for the ICAM-1Kilifi in other malaria-endemic regions, this allele was also found in Nigeria and Papua New Guinea, but not in Thailand.


Subject(s)
Intercellular Adhesion Molecule-1/genetics , Malaria, Falciparum/immunology , Plasmodium falciparum/pathogenicity , Point Mutation , Animals , Anti-Bacterial Agents/therapeutic use , Antimalarials/therapeutic use , Case-Control Studies , Child , Clindamycin/therapeutic use , DNA/chemistry , DNA Primers/chemistry , Deoxyribonucleases, Type II Site-Specific/chemistry , Drug Combinations , Electrophoresis, Agar Gel , Female , Gabon , Humans , Malaria, Falciparum/genetics , Male , Nigeria , Papua New Guinea , Parasitemia , Polymerase Chain Reaction , Pyrimethamine/therapeutic use , Quinine/therapeutic use , Sulfadoxine/therapeutic use , Thailand , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...